New study tracks heart Drug's effects during pregnancy and breastfeeding
NCT ID NCT05939700
First seen Nov 06, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This study monitors the health of women who took the heart medication mavacamten during pregnancy or while breastfeeding, along with their babies. Researchers will track pregnancy complications, birth outcomes, and infant development through the first year of life. The goal is to gather safety information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREASTFEEDING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
The Mavacamten Pregnancy Surveillance Program, PPD Inc
RECRUITINGWilmington, North Carolina, 28401-3331, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.